A deadly embrace: Hemagglutination mediated by SARS-CoV-2 spike protein at its 22 N-glycosylation sites, red blood cell surface sialoglycoproteins, and antibody

DE Scheim - International journal of molecular sciences, 2022 - mdpi.com
Rouleaux (stacked clumps) of red blood cells (RBCs) observed in the blood of COVID-19
patients in three studies call attention to the properties of several enveloped virus strains …

Coronavirus disease 2019 (COVID-19) and its neuroinvasive capacity: Is it time for melatonin?

A Romero, E Ramos, F Lopez-Munoz… - Cellular and molecular …, 2022 - Springer
The world faces an exceptional new public health concern caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), subsequently termed the coronavirus …

A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors

ASF Oliveira, AA Ibarra, I Bermudez, L Casalino… - Biophysical journal, 2021 - cell.com
Changeux et al.(Changeux et al. CR Biol. 343: 33–39.) recently suggested that the SARS-
CoV-2 spike protein may interact with nicotinic acetylcholine receptors (nAChRs) and that …

The human-restricted isoform of the α7 nAChR, CHRFAM7A: a double-edged sword in neurological and inflammatory disorders

S Di Lascio, D Fornasari, R Benfante - International Journal of Molecular …, 2022 - mdpi.com
CHRFAM7A is a relatively recent and exclusively human gene arising from the partial
duplication of exons 5 to 10 of the α7 neuronal nicotinic acetylcholine receptor subunit (α7 …

[HTML][HTML] An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations

MH Cheng, S Zhang, RA Porritt, M Arditi, I Bahar - BioRxiv, 2020 - ncbi.nlm.nih.gov
Abstract Multisystem Inflammatory Syndrome in Children (MIS-C) associated with
Coronavirus Disease 2019 (COVID-19) is a newly recognized condition in which children …

COVID‐19 breakthroughs: separating fact from fiction

P Dhillon, M Breuer, N Hirst - The FEBS journal, 2020 - Wiley Online Library
The newly recognised coronavirus SARS‐CoV‐2, causative agent of coronavirus disease
(COVID‐19), has caused a pandemic with huge ramifications for human interactions around …

Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats

C Chaccour, G Abizanda, Á Irigoyen-Barrio… - Scientific reports, 2020 - nature.com
Ivermectin is a widely used antiparasitic drug with known efficacy against several single-
strain RNA viruses. Recent data shows significant reduction of SARS-CoV-2 replication in …

Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain

A Vila-Córcoles, O Ochoa-Gondar, EM Satué-Gracia… - BMJ open, 2020 - bmjopen.bmj.com
Objective To investigate possible relationships between pre-existing medical conditions
(including common comorbidities and chronic medications) and risk for suffering COVID-19 …

Demographic and territorial characteristics of COVID-19 cases and excess mortality in the European Union during the first wave

A Goujon, F Natale, D Ghio, A Conte - Journal of Population Research, 2022 - Springer
This article explores for a large number of countries in the European Union (plus the United
Kingdom) the main demographic differentials in positive tested COVID-19 cases and excess …

Smoking and the risk of COVID-19 in a large observational population study

A Israel, E Feldhamer, A Lahad, D Levin-Zamir, G Lavie - MedRxiv, 2020 - medrxiv.org
BACKGROUND Smokers are generally more susceptible to infectious respiratory diseases
and are at higher risk of developing severe complications from these infections. Conflicting …